Project: Understanding the immunological basis of persistent airway obstruction in asthma
2021-01-01 – 2027-12-31
- Abstract
In severe asthma, there is persistent obstruction of the airways with mucus plugs containing mucins, fibrin, and Charcot-Leyden crystals. We hypothesize that plugged airways constitute a unique niche where type 2 immune cells thrive and communicate with structural cells to perpetuate disease. We will
study if eliminating plugs or key niche communication signals can treat persistent disease in mouse and man.
Show
Sort by
-
- Journal Article
- open access
Small-angle X-ray scattering of engineered antigen-binding fragments: the case of glycosylated Fab from the Mannitou IgM antibody.
-
- Journal Article
- A1
- open access
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa
-
- Journal Article
- A1
- open access
Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome
-
- Journal Article
- A1
- open access
A reappraisal of IL-9 in inflammation and cancer
-
- Journal Article
- A2
- open access
Case report : dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma : a proteome analysis
-
Interleukin-33-activated basophils promote asthma by regulating Th2 cell entry into lung tissue
-
- Journal Article
- A1
- open access
IL-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma
-
- Miscellaneous
- open access
TCR transgenic clone selection guided by immune receptor analysis and single cell RNA expression of polyclonal responders
(2024) -
- Journal Article
- A1
- open access
Sublingual allergen immunotherapy prevents house dust mite inhalant type 2 immunity through dendritic cell-mediated induction of Foxp3+ regulatory T cells
-
- Journal Article
- A1
- open access
Ym1 protein crystals promote type 2 immunity